Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the action

Nephrology

Volumn 21, Issue 7, 2016, Pages 535-546

  Mudge, David W ^a   Boudville, Neil ^b   Brown, Fiona ^c   Clayton, Philip ^g   Duddington, Michelle ^h   Holt, Stephen ^d,e   Johnson, David W ^a   Jose, Matthew ^j   Saweirs, Walaa ^k   Sud, Kamal ⁱ   Voss, David ^l   Walker, Rowan ^f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g ROYAL ADELAIDE HOSPITAL   (Australia)

^h Baxter Healthcare   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j UNIVERSITY OF TASMANIA   (Australia)

^k WHANGAREI HOSPITAL   (New Zealand)

^l MIDDLEMORE HOSPITAL   (New Zealand)

more..

Author keywords

continuous ambulatory peritoneal dialysis; outcome; peritoneal dialysis; peritonitis; quality indicator; technique survival

Indexed keywords

AGE; ANTIFUNGAL THERAPY; AUSTRALIA; BIOCOMPATIBILITY; CATHETER INFECTION; COMORBIDITY; DRUG THERAPY; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HEMODIALYSIS PATIENT; HUMAN; INFECTION; MEDICAL EDUCATION; NEW ZEALAND; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PREFERENCE; PATIENT SELECTION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROGNOSIS; PROPHYLAXIS; REVIEW; SELF CARE; SURVIVAL RATE; TREATMENT INDICATION;

EID: 84976601427     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12731     Document Type: Review

References (99)

1. Jose MD, Johnson DW, Mudge DW et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology 2011; 16: 19–29.
2. Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am. J. Kidney Dis. 2014; 64: 278–89.
3. McDonald SP. Key performance indicators, centre reports and more. Presentation at NSW Renal Club, 14 June 2012. [Cited 6 July 2015]. Available from URL: http://wwwanzdataorgau/v1/presentations.html
4. Ballinger AE, Palmer SC, Wiggins KJ et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst. Rev. 2014; 4: CD005284.
5. Kidney Health Australia. Caring for Australians with renal impairment: peritonitis treatment and prophylaxis. [Cited 14 June 2015]. Available from URL: http://www.cari.org.au/Dialysis/dialysis%20peritonitis/dialysis_peritonitis.html
6. Campbell DJ, Brown FG, Craig JC et al. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrol. Dial. Transplant. 2015; 10.1093/ndt/gfv115 (April 22, 2015).
7. Perl J, Robinson B, Davies S, International Society for Peritoneal Dialysis ARC, the Pi. Update on the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit. Dial. Int. 2014; 34: 332.
8. Perl J, Davies DJ, Lambie M, et al. The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit. Dial. Int. 2015; 10.3747/pdi.2014.00288 (2015).
9. Queensland Health. Clinical pathways. [Cited 7 July 2015]. Available from URL: https://wwwhealthqldgovau/caru/pathways/pathwaysasp#renal
10. Renal Health Clinical Network. Key performance indicator (KPI) project. 2013. [Cited 7 July 2015]. Available from URL: http://docs2healthvicgovau/docs/doc/389732B3956A9CCACA257D240077C8CF/$FILE/Renal%20KPI%20project%20data%20dictionary%20final%20version.pdf
11. Whittle A, Black K. Improving outcomes in peritoneal dialysis exit site care. RSAJ 2014; 10: 126–32.
12. Primary Care Partnerships (Victoria). Continuous Improvement Framework 2012: a resource of the Victorian Service Coordination Practice Manual. [Cited 8 July 2015]. Available from URL: http://wwwhealthvicgovau/pcps/downloads/continuous.pdf
13. Piraino B, Bernardini J, Brown E et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit. Dial. Int. 2011; 31: 614–30.
14. Just PM, de Charro FT, Tschosik EA, Noe LL, Bhattacharyya SK, Riella MC. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol. Dial. Transplant. 2008; 23: 2365–73.
15. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch. Intern. Med. 2011; 171: 110–8.
16. Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among ‘large’ ESRD patients in the United States. Kidney Int. 2004; 65: 2398–408.
17. Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol. Dial. Transplant. 2012; 27: 3568–75.
18. Nadeau-Fredette AC, Hawley CM, Pascoe EM et al. An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry). Clin. J. Am. Soc. Nephrol. 2015; doi: 10.2215/cjn.00840115 (2015, June 11).
19. Wang AY, Brimble KS, Brunier G et al. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I – assessment and management of various cardiovascular risk factors. Perit. Dial. Int. 2015; 35: 379–87.
20. Wang AY, Brimble KS, Brunier G et al. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II – management of various cardiovascular complications. Perit. Dial. Int. 2015; 35: 388–96.
21. Troidle L, Kliger A, Finkelstein F. Barriers to utilization of chronic peritoneal dialysis in network #1, New England. Perit. Dial. Int. 2006; 26: 452–7.
22. Davies SJ. Peritoneal dialysis – current status and future challenges. Nat. Rev. Nephrol. 2013; 9: 399–408.
23. Oliver MJ, Garg AX, Blake PG et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol. Dial. Transplant. 2010; 25: 2737–44.
24. Kitson A, Marshall A, Bassett K, Zeitz K. What are the core elements of patient-centred care? A narrative review and synthesis of the literature from health policy, medicine and nursing. J. Adv. Nurs. 2013; 69: 4–15.
25. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW, Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am. J. Kidney Dis. 2004; 43: 891–9.
26. Caring for Australasians with Renal Impairment (CARI) Guidelines. [Cited 4 March 2015]. Available from URL: http://www.cari.org.au/guidelines.php
27. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J. Am. Soc. Nephrol. 2003; 14: 2894–901.
28. Bernardini J, Price V, Figueiredo A, International Society for Peritoneal Dialysis Nursing Liaison Committee. Peritoneal dialysis patient training. Perit. Dial. Int. 2006; 26: 625–32.
29. Brown E, Harte-Armitage P, Hurst H, et al. Renal association working party on peritoneal dialysis final report. 18.11.2009. Renal Association, UK. [Cited 9 Feb 2015]. Available from URL: http://www.renal.org
30. Blake PG, Quinn RR, Oliver MJ. Peritoneal dialysis and the process of modality selection. Perit. Dial. Int. 2013; 33: 233–41.
31. Arramreddy R, Zheng S, Saxena AB, Liebman SE, Wong L. Urgent-start peritoneal dialysis: a chance for a new beginning. Am. J. Kidney Dis. 2014; 63: 390–5.
32. Liu FX, Ghaffari A, Dhatt H et al. Economic evaluation of urgent-start peritoneal dialysis versus urgent-start hemodialysis in the United States. Medicine 2014; 93: e293.
33. Masseur A, Guest S, Kumar V. Early technique success after initiation of treatment with urgent-start peritoneal dialysis. Adv Perit. Dial. 2014; 30: 36–9.
34. Unsal A, Basturk T, Koc Y et al. Factors associated with above and under 5-year survival in peritoneal dialysis patients. Ren. Fail. 2012; 34: 1129–34.
35. Kidney Health Australia. Consumer perspectives on dialysis: first national census. 2011. [Cited 13 July 2015]. Available from URL: http://wwwkidneyorgau/LinkClickaspx?fileticket=JfvirIbNWxA%3D
36. Walker RC, Marshall MR. Increasing the uptake of peritoneal dialysis in New Zealand: a national survey. J. Ren. Care 2014; 40: 40–8.
37. Li PK, Chow KM. Peritoneal dialysis-first policy made successful: perspectives and actions. Am. J. Kidney Dis. 2013; 62: 993–1005.
38. Ho Y-W, Chau K-F, Choy B-Y et al. Hong Kong Renal Registry Report 2012. J. Nephrol. (Hong Kong) 2013; 15: 28–43.
39. Lo WK. Peritoneal dialysis in the far East – an astonishing situation in 2008. Perit. Dial. Int. 2009; 29 (Suppl 2): S227–9.
40. Dhanakijcharoen P, Sirivongs D, Aruyapitipan S, Chuengsaman P, Lumpaopong A. The ‘PD First’ policy in Thailand: three-years experiences (2008–2011). J. Med. Assoc. Thai. 2011; 94 (Suppl 4): S153–61.
41. Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit. Dial. Int. 2014. DOI: 10.3747/pdi.2013.00204.
42. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J. Am. Soc. Nephrol. 2009; 20: 155–63.
43. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int. Suppl. 2006; 103: S3–11.
44. Nishina M, Yanagi H, Kakuta T, Endoh M, Fukagawa M, Takagi A. A 10-year retrospective cohort study on the risk factors for peritoneal dialysis-related peritonitis: a single-center study at Tokai University Hospital. Clin. Exp. Nephrol. 2014; 18: 649–54.
45. Tsai CC, Lee JJ, Liu TP et al. Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis. Surg. Infect. (Larchmt.) 2013; 14: 540–6.
46. Cheng CH, Shu KH, Chuang YW, Huang ST, Chou MC, Chang HR. Clinical outcome of elderly peritoneal dialysis patients with assisted care in a single medical centre: a 25 year experience. Nephrology 2013; 18: 468–73.
47. Barraclough K, Hawley CM, McDonald SP et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am. J. Kidney Dis. 2010; 55: 121–31.
48. Cho Y, Badve SV, Hawley CM et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol. 2012; 13: 41.
49. Nayak A, Antony S, Nayak KS. Remote monitoring of peritoneal dialysis in special locations. Contrib. Nephrol. 2012; 178: 79–82.
50. Unsal A, Koc Y, Basturk T et al. Clinical outcomes and mortality in peritoneal dialysis patients: a 10-year retrospective analysis in a single center. Clin. Nephrol. 2013; 80: 270–9.
51. Badve SV, Smith A, Hawley CM, Johnson DW. Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. NDT Plus 2009; 2: 508.
52. Chen JL, Mehrotra R, Kalantar-Zadeh K. Surviving the first year of peritoneal dialysis: enduring hard times. Am. J. Kidney Dis. 2014; 64: 673–6.
53. Walker A, Bannister K, George C et al. KHA-CARI Guideline: peritonitis treatment and prophylaxis. Nephrology 2014; 19: 69–71.
54. Mitra A, Teitelbaum I. Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines. Adv Perit. Dial. 2003; 19: 255–9.
55. McQuillan RF, Chiu E, Nessim S et al. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin. J. Am. Soc. Nephrol. 2012; 7: 297–303.
56. Nunez-Moral M, Sanchez-Alvarez E, Gonzalez-Diaz I et al. Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. Results of a prospective randomized trial. Perit. Dial. Int. 2014; 34: 271–7.
57. van Diepen AT, Jassal SV. A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis. Perit. Dial. Int. 2013; 33: 604–10.
58. van Diepen AT, Tomlinson GA, Jassal SV. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol. 2012; 7: 1266–71.
59. Bernardini J, Bender F, Florio T et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 2005; 16: 539–45.
60. Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit. Dial. Int. 2012; 32: 525–30.
61. Johnson DW, Badve SV, Pascoe EM et al. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect. Dis. 2014; 14: 23–30.
62. Piraino B, Bailie GR, Bernardini J et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit. Dial. Int. 2005; 25: 107–31.
63. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am. J. Kidney Dis. 2004; 44: 591–603.
64. Miles R, Hawley CM, McDonald SP et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009; 76: 622–8.
65. Burke M, Hawley CM, Badve SV et al. Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study. Am. J. Kidney Dis. 2011; 58: 429–36.
66. Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit. Dial. Int. 2010; 30: 619–25.
67. Johnson DW, Brown FG, Clarke M et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J. Am. Soc. Nephrol. 2012; 23: 1097–107.
68. Johnson DW, Brown FG, Clarke M et al. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit. Dial. Int. 2012; 32: 497–506.
69. Howard K, Hayes A, Cho Y, Cass A, Clarke M, Johnson DW. Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ trial. Am. J. Kidney Dis. 2015; 65: 773–9.
70. Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int. 2013; 84: 969–79.
71. Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst. Rev. 2014; 3: CD007554.
72. Wang AYM, Brimble KS, Brunier G, et al. ISPD guidelines on assessment and management of various cardiovascular risk factors in chronic adult peritoneal dialysis patients. Perit. Dial. Int. 2015 (in press).
73. Seo EY, An SH, Cho JH et al. Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials. Perit. Dial. Int. 2014; 34: 724–31.
74. Wang J, Zhu N, Yuan W. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis. Nephron 2015; 129: 155–63.
75. Yohanna S, Alkatheeri AM, Brimble SK et al. Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 2015; doi: 10.2215/cjn.05410514 (2015, June 5).
76. Brown EA. How to address barriers to peritoneal dialysis in the elderly. Perit. Dial. Int. 2011; 31 (Suppl 2): S83–5.
77. Moore R, Teitelbaum I. Preventing burnout in peritoneal dialysis patients. Adv Perit. Dial. 2009; 25: 92–5.
78. Kalirao P, Pederson S, Foley RN et al. Cognitive impairment in peritoneal dialysis patients. Am. J. Kidney Dis. 2011; 57: 612–20.
79. George S, Holt S, Medford N, Hildick-Smith D. Does a patent foramen ovale influence cognitive function in dialysis patients? Nephron Clin. Pract. 2013; 123: 1–6.
80. Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K. Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin. J. Am. Soc. Nephrol. 2012; 7: 2002–9.
81. Aydede SK, Komenda P, Djurdjev O, Levin A. Chronic kidney disease and support provided by home care services: a systematic review. BMC Nephrol. 2014; 15: 118.
82. Taskapan H, Tam P, Leblanc D et al. Peritoneal dialysis in the nursing home. Int. Urol. Nephrol. 2010; 42: 545–51.
83. Laplante S, Krepel H, Simons B, Nijhoff A, van Liere R, Simons M. Offering assisted peritoneal dialysis is a cost-effective alternative to the current care pathway in frail elderly Dutch patients. Int. J. Healthc. Manag. 2013; 6: 27–36.
84. Blake PG. Individualized prescription of peritoneal dialysis therapy? Perit. Dial. Int. 1999; 19 (Suppl 2): S495–8.
85. Turner G, Clegg A. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing 2014; 43: 744–7.
86. International Society for Peritoneal Dialysis and the University of Pittsburgh. Teaching nurses to teach: peritoneal dialysis training, 2006. [Cited 22 Jan 2015]. Available from URL: http://ispd.org/PD_Video/index.html
87. Campbell DJ, Johnson DW, Mudge DW, Gallagher MP, Craig JC. Prevention of peritoneal dialysis-related infections. Nephrol. Dial. Transplant. 2014; doi: 10.1093/ndt/gfu313 (2014, October 7).
88. Zhang L, Hawley C, Johnson DW. Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrol. Dial. Transplant. 2015 (in press). DOI: 10.1093/ndt/gfu403.
89. Boudville N, Dent H, McDonald SP, Hurst K, Clayton P. Peritoneal dialysis. In: McDonald SP (ed.). ANZDATA Registry Report, Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, 2013.
90. Yang ZK, Han QF, Zhu TY et al. The associations between the family education and mortality of patients on peritoneal dialysis. PLoS One 2014; 9: e95894.
91. Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service Standards. 2012. [Cited 13 July 2015]. Available from URL: http://wwwsafetyandqualitygovau/wp-content/uploads/2011/09/NSQHS-Standards-Sept-2012.pdf
92. The Royal Australian College of Physicians. Physician readiness for expert practice (PREP) training program: nephrology advanced training curriculum. 2013. [Cited 9 Feb 2015]. Available from URL: https://www.racp.edu.au/page/advanced-curricula
93. British Renal Association. Guidelines Peritoneal Dialysis 15/5/2007. [Cited 4 Mar 2015]. Available from URL: http://www.renal.org/Clinical/GuidelinesSection/PeritonealDialysis.aspx#summary_s5
94. Chow KM, Szeto CC, Law MC, Fun Fung JS, Kam-Tao LP. Influence of peritoneal dialysis training nurses' experience on peritonitis rates. Clin. J. Am. Soc. Nephrol. 2007; 2: 647–52.
95. Diaz-Buxo JA, Wick GS, Pesich AA. Using CQI techniques for managing infections in PD patients. Nephrol. News Issues 1998; 12: 22–4.
96. Flanigan M, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit. Dial. Int. 2005; 25: 132–9.
97. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J. Am. Soc. Nephrol. 2004; 15: 2735–46.
98. Afolalu B, Troidle L, Osayimwen O, Bhargava J, Kitsen J, Finkelstein FO. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit. Dial. Int. 2009; 29: 292–6.
99. Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. Association of peritoneal dialysis clinic size with clinical outcomes. Perit. Dial. Int. 2009; 29: 285–91.